Marinomed Biotech AG, ATMARINOMED6

Marinomed Biotech AG / ATMARINOMED6

26.09.2024 - 09:15:03

Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution

EQS Voting Rights Announcement: Marinomed Biotech AG


26.09.2024 / 09:15 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.



Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018   Wien,  24.9.2024   Overview ? Notification made after deadline Caution: In case of violations of major holdings notification rules, please pay attention to Section 137 BörseG 2018 (Suspension of voting rights)   1. Issuer: Marinomed Biotech AG
2. Reason for the notification: Event changing the breakdown of voting rights
3. Person subject to notification obligation
Name: Österreichische Beamtenversicherung, Versicherungsverein auf Gegenseitigkeit
City: 1016 Wien
Country: Österreich
4. Name of shareholder(s): 
5. Date on which the threshold was crossed or reached: 18.9.2024   6. Total positions
   
% of voting rights attached to shares (7.A)
% of voting rights through financial/other instruments (7.B.1 + 7.B.2)  
 
Total of both in % (7.A + 7.B)
 
Total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed / reached  
3,71 %
 
0,00 %
 
3,71 %
 
1 694 583
Position of previous notification (if applicable)  
4,08 %
 
 
 
 
 
  Details 7. Notified details of the resulting situation:  
A: Voting rights attached to shares

ISIN Code
Number of voting rights % of voting rights
Direct
(Sec 130 BörseG 2018)
Indirect
(Sec 133 BörseG 2018)
Direct
(Sec 130 BörseG 2018)
Indirect
(Sec 133 BörseG
2018)
ATMARINOMED6 62 916   3,71 %  
SUBTOTAL A 62 916 3,71 %
 
B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018

Type of instrument

Expiration Date

Exercise Period
Number of voting
rights that may be
acquired if the
instrument is exercised

% of voting rights
         
    SUBTOTAL B.1    
 
B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018
Type of instrument Expiration Date Exercise Period Physical /
Cash Settlement
Number of
voting rights
% of voting rights
           
      SUBTOTAL B.2    
 
8. Information in relation to the person subject to the notification obligation: ? Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer. ? Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:
 
9. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights.
10. Sonstige Kommentare: Per 18. September  2024 erfolgte eine 10%ige Kapitalerhöhung des Grundkapitals der Marinomed AG (ATMARINOMED6). Die Österreichische Beamtenversicherung, Versicherungsverein auf Gegenseitigkeit, hat an dieser Kapitalerhöhung nicht teilgenommen und hält unverändert 62.916 Aktien der Gesellschaft. Ihr Anteil an der Marinomed AG reduzierte sich dadurch von 4,08% auf 3,71%.
   Wien am  24.9.2024  


26.09.2024 CET/CEST

Language: English
Company: Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg
Austria
Internet: www.marinomed.com

 
End of News EQS News Service

1995919  26.09.2024 CET/CEST fncls.ssp?fn=show_t_gif&application_id=1995919&application_name=news&site_id=trading_house_net~~~7efceac5-959a-43d6-afef-21ad42b6a5d4
@ dgap.de